XML 56 R40.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Quarterly Financial Data (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2015 | Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract] |  |
Schedule of Quarterly Financial Information [Table Text Block] | respectively.
| Three Months Ended
(in thousands, except per share data) | March 31, 2015 |  | June 30, 2015 |  | September 30, 2015 |  | December 31, 2015
Revenues | $ | 3,172 |  |  | $ | 5,867 |  |  | $ | 5,888 |  |  | $ | 7,560 |
Total operating costs and expenses | $ | 21,260 |  |  | $ | 31,536 |  |  | $ | 16,271 |  |  | $ | 67,269 |
Net loss | $ | (19,231 | ) |  | $ | (17,158 | ) |  | $ | (11,393 | ) |  | $ | (33,228 | )
Net loss attributable to Caladrius Biosciences, Inc. common stockholders | $ | (19,187 | ) |  | $ | (17,126 | ) |  | $ | (11,376 | ) |  | $ | (33,197 | )
Basic and diluted loss per share attributable to Caladrius Biosciences, Inc. common stockholders | $ | (0.51 | ) |  | $ | (0.38 | ) |  | $ | (0.21 | ) |  | $ | (0.59 | )
| Three Months Ended
(in thousands, except per share data) | March 31, 2014 |  | June 30, 2014 |  | September 30, 2014 |  | December 31, 2014
Revenues | $ | 4,056 |  |  | $ | 4,489 |  |  | $ | 4,118 |  |  | $ | 5,276 |
Total operating costs and expenses | $ | 17,555 |  |  | $ | 16,919 |  |  | $ | 20,376 |  |  | $ | 20,830 |
Net loss | $ | (13,830 | ) |  | $ | (12,769 | ) |  | $ | (17,177 | ) |  | $ | (11,691 | )
Net loss attributable to Caladrius Biosciences, Inc. common stockholders | $ | (13,682 | ) |  | $ | (12,605 | ) |  | $ | (16,974 | ) |  | $ | (11,612 | )
Basic and diluted loss per share attributable to Caladrius Biosciences, Inc. common stockholders | $ | (0.49 | ) |  | $ | (0.40 | ) |  | $ | (0.48 | ) |  | $ | (0.32 | )

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the quarterly financial data in the annual financial statements. The disclosure includes financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a)-(j) -URI http://asc.fasb.org/extlink&oid=51825399&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration